Kidney TransplantationArchives
The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review
Kidney Transplantation 4 min.
Kidney transplantation is a treatment most frequently used for patients suffering from end-stage renal disease (ESRD) which may provide the best opportunity for long-term and dialysis-free survival [1]. However, intraoperative hypotension often occurs in the post-anastomosis reperfusion stage, which...
Rituximab in antibody-mediated rejection following kidney transplantation: clinical and pathological outcomes
Kidney Transplantation 5 min.
The primary therapeutic in the management of acute antibody-mediated rejection (AMR) are to diminish pathogenic donor-specific antibody (DSA) titers, eradicate the clonal B cell or plasma cell populations responsible for their synthesis, inhibit complement activation, mitigate endothelial injury, and...
Gut microbiota and metabolomic profiles of tacrolimus-induced DILI in renal transplant recipients: a population-based case control study
Kidney Transplantation 6 min.
Renal transplant recipients generally require maintenance immunosuppressive therapy to prevent acute rejection and preserve graft function. To date, cases of drug-induced liver injury (DILI) in renal transplant recipients on Tac immunosuppressive regimens have been reported, but incidence estimates vary...
Factors associated with the willingness to become a kidney transplant recipient ─ the results from a national cross sectional study
Kidney Transplantation 7 min.
Currently, kidney transplantation (KT) is considered to be the best treatment option of renal replacement therapy (RRT) in patients with an end stage renal disease (ESRD), providing them significantly better outcomes and improved quality of life (QOL) [1, 2]. Additionally, the 5 yrs. survival rate comparison...
